|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0022341,
umls-concept:C0030705,
umls-concept:C0040808,
umls-concept:C0205420,
umls-concept:C0282461,
umls-concept:C0441771,
umls-concept:C0684249,
umls-concept:C0817096,
umls-concept:C1515417,
umls-concept:C1518578,
umls-concept:C1519810,
umls-concept:C1522449,
umls-concept:C1705493
|
|
pubmed:issue |
23
|
|
pubmed:dateCreated |
2010-8-9
|
|
pubmed:abstractText |
This phase III trial of concurrent thoracic radiotherapy (TRT) was conducted to compare third-generation chemotherapy with second-generation chemotherapy in patients with unresectable stage III non-small-cell lung cancer (NSCLC).
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:ChibaYasutakaY,
pubmed-author:FukuokaMasahiroM,
pubmed-author:HidaToyoakiT,
pubmed-author:ImamuraFumioF,
pubmed-author:IwamotoYasuoY,
pubmed-author:KatakamiNobuyukiN,
pubmed-author:KawaharaMasaakiM,
pubmed-author:KudoShinzohS,
pubmed-author:NakagawaKazuhikoK,
pubmed-author:NishimuraYasumasaY,
pubmed-author:SakaHideoH,
pubmed-author:SatouchiMiyakoM,
pubmed-author:SawaToshiyukiT,
pubmed-author:SembaHiroshiH,
pubmed-author:SetoTakashiT,
pubmed-author:TakedaKojiK,
pubmed-author:TsujinoKayokoK,
pubmed-author:UejimaHisaoH,
pubmed-author:YamamotoNobuyukiN,
pubmed-author:YokotaSoichiroS
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
10
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3739-45
|
|
pubmed:dateRevised |
2011-5-25
|
|
pubmed:meshHeading |
pubmed-meshheading:20625120-Adult,
pubmed-meshheading:20625120-Aged,
pubmed-meshheading:20625120-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20625120-Camptothecin,
pubmed-meshheading:20625120-Carboplatin,
pubmed-meshheading:20625120-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:20625120-Cisplatin,
pubmed-meshheading:20625120-Combined Modality Therapy,
pubmed-meshheading:20625120-Female,
pubmed-meshheading:20625120-Humans,
pubmed-meshheading:20625120-Lung Neoplasms,
pubmed-meshheading:20625120-Male,
pubmed-meshheading:20625120-Middle Aged,
pubmed-meshheading:20625120-Mitomycin,
pubmed-meshheading:20625120-Paclitaxel,
pubmed-meshheading:20625120-Radiotherapy, Adjuvant,
pubmed-meshheading:20625120-Vindesine
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105.
|
|
pubmed:affiliation |
Kinki University Hospital, Osaka-Sayama, Japan. n.yamamoto@scchr.jp
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Clinical Trial, Phase III
|
